166 related articles for article (PubMed ID: 31724162)
1. LCMV-specific CD4 T cell dependent polyclonal B-cell activation upon persistent viral infection is short lived and extrafollicular.
Greczmiel U; Kräutler NJ; Borsa M; Pedrioli A; Bartsch I; Richter K; Agnellini P; Bedenikovic G; Oxenius A
Eur J Immunol; 2020 Mar; 50(3):396-403. PubMed ID: 31724162
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
3. Residual LCMV antigen in transiently CD4
Schweier O; Aichele U; Marx AF; Straub T; Verbeek JS; Pinschewer DD; Pircher H
Eur J Immunol; 2019 Apr; 49(4):626-637. PubMed ID: 30636035
[TBL] [Abstract][Full Text] [Related]
4. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
[TBL] [Abstract][Full Text] [Related]
5. Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.
Wieland A; Shashidharamurthy R; Kamphorst AO; Han JH; Aubert RD; Choudhury BP; Stowell SR; Lee J; Punkosdy GA; Shlomchik MJ; Selvaraj P; Ahmed R
Immunity; 2015 Feb; 42(2):367-378. PubMed ID: 25680276
[TBL] [Abstract][Full Text] [Related]
6. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
Richter K; Oxenius A
Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes.
Mothé BR; Stewart BS; Oseroff C; Bui HH; Stogiera S; Garcia Z; Dow C; Rodriguez-Carreno MP; Kotturi M; Pasquetto V; Botten J; Crotty S; Janssen E; Buchmeier MJ; Sette A
J Immunol; 2007 Jul; 179(2):1058-67. PubMed ID: 17617598
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice.
Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB
J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468
[TBL] [Abstract][Full Text] [Related]
10. Analyzing Mouse B Cell Responses Specific to LCMV Infection.
Hao Y; Li Z; Wang Y; Liu X; Ye L
Methods Mol Biol; 2018; 1707():15-38. PubMed ID: 29388097
[TBL] [Abstract][Full Text] [Related]
11. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
[TBL] [Abstract][Full Text] [Related]
12. B cell-derived IL-27 promotes control of persistent LCMV infection.
Pratumchai I; Zak J; Huang Z; Min B; Oldstone MBA; Teijaro JR
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35022243
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Fibrinogen-Like Protein 2:FcγRIIB/RIII immunosuppressive pathway enhances antiviral T-cell and B-cell responses leading to clearance of lymphocytic choriomeningitis virus clone 13.
Luft O; Khattar R; Farrokhi K; Ferri D; Yavorska N; Zhang J; Sadozai H; Adeyi O; Chruscinski A; Levy GA; Selzner N
Immunology; 2018 Jul; 154(3):476-489. PubMed ID: 29341118
[TBL] [Abstract][Full Text] [Related]
14. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
[TBL] [Abstract][Full Text] [Related]
15. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
16. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation.
Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM
Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection.
Yamada DH; Elsaesser H; Lux A; Timmerman JM; Morrison SL; de la Torre JC; Nimmerjahn F; Brooks DG
Immunity; 2015 Feb; 42(2):379-390. PubMed ID: 25680277
[TBL] [Abstract][Full Text] [Related]
19. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
20. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen.
Jellison ER; Guay HM; Szomolanyi-Tsuda E; Welsh RM
Eur J Immunol; 2007 Jan; 37(1):119-28. PubMed ID: 17163452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
